Bayer (BAYRY) Canada announced a new partnership with Mint Pharmaceuticals for the distribution of ADALAT XL 30 mg tablets in Canada. This strategic collaboration took effect on September 3, 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAYRY:
- Bristol Myers commitment a reminder of Veeva’s progress, says Stifel
- Bayer announces progress for two potential therapies for Parkinson’s disease
- Oppenheimer maintains bullish stance on Corteva following split reports
- Morgan Stanley says Corteva may want to get out in front of ag landscape changes
- Bayer announces new drug application for gadoquatrane accepted for review by FDA